172 related articles for article (PubMed ID: 28204991)
1. Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats.
Nakashima T; Uematsu N; Sakurai K
Support Care Cancer; 2017 Jul; 25(7):2205-2213. PubMed ID: 28204991
[TBL] [Abstract][Full Text] [Related]
2. Novel submicronized rebamipide liquid with moderate viscosity: significant effects on oral mucositis in animal models.
Nakashima T; Sako N; Matsuda T; Uematsu N; Sakurai K; Ishida T
Biol Pharm Bull; 2014; 37(4):671-8. PubMed ID: 24694614
[TBL] [Abstract][Full Text] [Related]
3. Establishment of an X-ray irradiation-induced glossitis model in rats: biphasic elevation of proinflammatory cytokines and chemokines.
Nakashima T; Uematsu N; Shibamori M; Sakurai K; Ishida T
J Pharmacol Exp Ther; 2013 Dec; 347(3):660-8. PubMed ID: 24060545
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis.
Okayama M; Tsubouchi R; Nishio H; Kato S; Takeuchi K
Digestion; 2004; 70(4):240-9. PubMed ID: 15687726
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.
Nakashima T; Maeda T; Nagamoto H; Kumakura T; Takai M; Mori T
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S124-31. PubMed ID: 16184415
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice.
Jang H; Park S; Lee J; Myung JK; Jang WS; Lee SJ; Myung H; Lee C; Kim H; Lee SS; Jin YW; Shim S
J Gastroenterol Hepatol; 2018 Apr; 33(4):878-886. PubMed ID: 29047150
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats.
Kishimoto S; Fujimura J; Machino H; Shimamoto T; Kobayashi H; Shimizu S; Haruma K; Kajiyama G; Sakurai K; Yamasaki K
Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):259-77. PubMed ID: 1335596
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy.
Takeuchi I; Kamiki Y; Makino K
Colloids Surf B Biointerfaces; 2018 Jul; 167():468-473. PubMed ID: 29723818
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
11. Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine.
Arakawa T; Watanabe T; Fukuda T; Yamasaki K; Kobayashi K
Dig Dis Sci; 1995 Nov; 40(11):2469-72. PubMed ID: 7587834
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
Shibamori M; Sato M; Uematsu N; Nakashima T; Sato A; Yamamura Y; Sasabe H; Umehara K; Sakurai K
J Pharmacol Sci; 2015 Sep; 129(1):18-25. PubMed ID: 26320673
[TBL] [Abstract][Full Text] [Related]
13. Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Wood RC; Wyatt JE; Bullins KW; Hanley AV; Hanley GA; Denham JW; Panus PC; Harirforoosh S
Eur J Pharmacol; 2013 Nov; 720(1-3):138-46. PubMed ID: 24365796
[TBL] [Abstract][Full Text] [Related]
14. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
Udagawa A; Shiota G; Ichiba M; Murawaki Y
Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.
Mizoguchi H; Ogawa Y; Kanatsu K; Tanaka A; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2001 Oct; 16(10):1112-9. PubMed ID: 11686837
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.
Aihara E; Hayashi S; Amagase K; Kato S; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):196-202. PubMed ID: 17943251
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer].
Enami A; Masuda N; Yamamura J; Mizutani M; Yasojima H; Shikata A; Masaoka M; Takada S; Bamba N; Yamamoto M; Abe M; Makihara K
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1407-12. PubMed ID: 25434444
[TBL] [Abstract][Full Text] [Related]
18. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732
[TBL] [Abstract][Full Text] [Related]
19. [Pilot study on clinical effects of rebamipide gargle against oral mucositis induced by fluoropyrimidines].
Kabeya M; Ina K; Yuasa S; Kikuchi F; Tajiri C; Kato T; Hibi S; Minagawa Y; Furuta R; Kayukawa S; Kataoka T; Kawai M
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1133-6. PubMed ID: 21772097
[TBL] [Abstract][Full Text] [Related]
20. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
